VYNE Therapeutics (NASDAQ:VYNE) reported its Q1 earnings results on Thursday, May 11, 2023 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
VYNE Therapeutics beat estimated earnings by 43.3%, reporting an EPS of $-1.48 versus an estimate of $-2.61.
Revenue was down $79 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.27 which was followed by a 13.0% drop in the share price the next day.
Here’s a look at VYNE Therapeutics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -3.24 | -3.06 | -3.06 | -2.88 |
| EPS Actual | -2.97 | -2.52 | -2.34 | 1.80 |
| Revenue Estimate | 60K | 130K | 100K | 370K |
| Revenue Actual | 6K | 167K | 126K | 178K |
To track all earnings releases for VYNE Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
